Search For "dcgi"
DCGI issues advisory to states/UTs medical professionals on theft of insul
Updated : 1 week, 2 days ago IST
The DCGI (Drugs Controller General of India) on Wednesday issued an alert regarding a stolen batch of Sanofi India's insulin formulation, Lantus SoloStar (Insulin Glargine Injection IP, r-DNA origin, 100 IU/mL), with batch number 5F0347B.
Read More
DCGI issues directive to states, UTs on strict compliance with drug testin
Updated : 5 months ago IST
In a letter dated October 7, the Drugs Controller General of India (DCGI) Dr Rajeev Singh Raghuvanshi emphasised the "critical importance of testing new materials, including the excipients, before their use in the manufacturing of pharmaceutical formulations."
Read More
DCGI alerts doctors, health professionals on theft of multiple drug produc
Updated : 6 months, 3 weeks ago IST
The DCGI has also mentioned in the notice that the quality of the injectables is required to be stored at 2-8 degrees Celsius; if not handled properly, storage quality might be compromised.
Read More
Akums Reports Q1 FY26 with 19% YoY Adj EBITDA Growth; Achieves 1,000 DCGI
Updated : 7 months, 1 week ago IST
New Delhi [India], August 9: Akums Drugs and Pharmaceuticals Ltd., India's largest contract development and manufacturing organization (CDMO), has announced its consolidated financial results for the quarter ended June 30, 2025. This quarter continued to display strong performance with healt
Read More
Delhi HC directs DCGI to examine weight loss drug combinations, instructs
Updated : 8 months, 2 weeks ago IST
The Delhi High Court has directed the Drug Controller General of India (DCGI) to examine and address issues raised in a petition challenging the approval and sale of certain weight loss drug combinations in India.
Read More
DCGI reduces blood bank licensing time to 4 months with digital process
Updated : 1 year, 3 months ago IST
The Drugs Controller General of India (DCGI) has reduced the time required for blood bank licensing from a year to a maximum of four months by transitioning the entire process to a digital platform.
Read More
11 countries already recognise Indian pharmacopoeia as their standard: DCG
Updated : 1 year, 5 months ago IST
Drugs Controller General of India (DCGI) Dr Rajeev Raghuvanshi, has said that 11 countries in the world have recognised Indian pharmacopoeia as their standard.
Read More
DCGI constantly monitoring quality of medicines and taking action, says to
Updated : 1 year, 5 months ago IST
As per senior official sources, the DCGI is actively taking action against manufacturing companies producing drugs that do not meet the required standards of quality (NSQ). This proactive approach aims to protect public health and maintain trust in the healthcare system.
Read More
ENTOD meets Drug Controller General of India, issues clarification for Pre
Updated : 1 year, 5 months ago IST
Mumbai-based ENTOD Pharmaceuticals met with the Drug Controller General of India (DCGI) earlier this week to address concerns surrounding PresVu eye drops, which were approved for treating presbyopia in adults on August 6. However, the drug controller suspended its permission on September 10
Read More
Entod pharma to move court against DCGI's order suspending PresVu eye drop
Updated : 1 year, 6 months ago IST
The drug regulator suspended permission, citing the company's failure to respond to the queries on the product for which the DCGI says "no approval was granted."
Read More
Drug regulator suspends product PresVu over unauthorised promotion
Updated : 1 year, 6 months ago IST
The Drugs Controller General of India (DCGI) on Wednesday suspended the product PresVu produced by Entod Pharmaceuticals after the company failed to respond to the queries on the product for which the DGCI says no approval was granted.
Read More
"Unethical and false presentation of facts" by Entod Pharmaceuticals on Pr
Updated : 1 year, 6 months ago IST
The ENTOD Pharmaceuticals claiming PresVU eye drops approved by DCGI offering spectacular treatment for Presbyopia, making with spectacles is unethical and false presentation, said a top official source to ANI.
Read More